Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients

Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7). Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7). Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7). Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7). Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7). ForsLean Increases Lean Body Mass and Reduces Body Fat Percentages According to Recent Study 12-week randomized, double-blind, placebo-controlled study of 50 obese men and women revealed that subjects receiving ForsLean had a statistically significant increase in lean body mass of 1.78 percent compared to a 0.20 percent decrease in the placebo group. ForsLean Increases Lean Body Mass and Reduces Body Fat Percentages According to Recent Study 12-week randomized, double-blind, placebo-controlled study of 50 obese men and women revealed that subjects receiving ForsLean had a statistically significant increase in lean body mass of 1.78 percent compared to a 0.20 percent decrease in the placebo group. ForsLean Increases Lean Body Mass and Reduces Body Fat Percentages According to Recent Study 12-week randomized, double-blind, placebo-controlled study of 50 obese men and women revealed that subjects receiving ForsLean had a statistically significant increase in lean body mass of 1.78 percent compared to a 0.20 percent decrease in the placebo group. ForsLean Increases Lean Body Mass and Reduces Body Fat Percentages According to Recent Study 12-week randomized, double-blind, placebo-controlled study of 50 obese men and women revealed that subjects receiving ForsLean had a statistically significant increase in lean body mass of 1.78 percent compared to a 0.20 percent decrease in the placebo group. NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis". NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit.	SALT LAKE CITY, Utah, Nov. 17 /PRNewswire/ -- A major new study provides good news in the fight against Alzheimer's, as Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company) has been shown to improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical patients. Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International (ADI).(1) "This study shows EGb 761(R) is effective in typical Alzheimer's cases," says Professor A. Napreyenko, principal investigator of the study. "In patients exhibiting the full range of cognitive and non-cognitive features of dementia, EGb 761(R) improves cognitive functioning as well as neuropsychiatric symptoms and activities of daily living." 395 outpatients with mild to moderate dementia and neuropsychiatric symptoms (such as depressed mood, anxiety, irritability and indifference) participated in the study. Patients with these symptoms represent the overwhelming majority of Alzheimer's cases in clinical practice. Patients received either 240 mg of EGb 761(R) or placebo daily. The primary outcome measure in the cognitive domain was the SKT test battery, an internationally validated rating scale for dementia. In the neuropsychiatric domain the Neuropsychiatric Inventory (NPI) and the Hamilton Rating Scale for Depression (HAMD) were applied. After 22 weeks, patients given EGb 761(R) showed clear improvement and a highly significant difference of 4.5 points compared to those receiving placebo (p < 0.001, 2-sample t-test). Similar statistically significant improvements were found for the EGb 761(R) group on all secondary outcome measures. EGb 761(R) was also well tolerated. Positive results of this study confirm earlier findings, including the breakthrough twelve-month U.S. trial by Le Bars et al published in the Journal of the American Medical Association (JAMA, 1997), in which EGb 761(R) was shown to stabilize, and in some cases improve, the cognitive performance and social functioning of Alzheimer's patients.(2) EGb 761(R) is a patented Ginkgo biloba extract with a unique profile of constituents developed and manufactured by the Dr. Willmar Schwabe Company, Karlsruhe, Germany. It is sold in the U.S. under the Ginkgold(R) brand name. EGb 761(R) is recognized worldwide as the best researched phytomedicine. (1) Napreyenko A, Ihl R, Schlaefke S, Hoerr R. Ginkgo biloba Extract EGb 761(R) in the Treatment of Dementia with Neuropsychiatric Features: A Randomized, Placebo-controlled, Double-blind Trial. Poster presentation at the 21st International Conference of Alzheimer's Disease International (ADI) in Istanbul, Turkey, September 2005. (2) Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A Placebo-controlled, Double-blind, Randomized Trial of an Extract of Ginkgo biloba for Dementia. JAMA 1997, 278(16):1327-32.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software